Secondary Logo

Journal Logo

November 2004 - Volume 32 - Issue 11
pp: 2173-2369

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels*

Panacek, Edward A.; Marshall, John C.; Albertson, Timothy E.; More

Critical Care Medicine. 32(11):2173-2182, November 2004.




Continuing Medical Education











Show: